Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Cellebrite DI Ltd’s stock clocked out at $19.61, down -1.70% from its previous closing price of $19.95. In other words, the price has decreased by -$1.70 from its previous closing price. On the day, 0.92 million shares were traded. CLBT stock price reached its highest trading level at $19.74 during the session, while it also had its lowest trading level at $19.28.
Ratios:
To gain a deeper understanding of CLBT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.50 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.99. For the most recent quarter (mrq), Quick Ratio is recorded 1.87 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on March 28, 2024, Reiterated its Buy rating but revised its target price to $13.50 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on February 16, 2024, whereas the target price for the stock was revised from $9 to $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 25 ’25 when LEEOR MOSHE BEN-PERETZ bought 18,512 shares for $20.36 per share.
LEEOR MOSHE BEN-PERETZ bought 15,680 shares of CLBT for $296,920 on Mar 19 ’25. On Mar 17 ’25, another insider, YOSEF CARMIL, who serves as the Officer of the company, bought 200,000 shares for $18.25 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLBT now has a Market Capitalization of 4777427456 and an Enterprise Value of 4259753984. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.70 while its Price-to-Book (P/B) ratio in mrq is 13.69. Its current Enterprise Value per Revenue stands at 10.617 whereas that against EBITDA is 63.095.
Stock Price History:
The Beta on a monthly basis for CLBT is 1.46, which has changed by 0.78110814 over the last 52 weeks, in comparison to a change of 0.08572841 over the same period for the S&P500. Over the past 52 weeks, CLBT has reached a high of $26.30, while it has fallen to a 52-week low of $10.24. The 50-Day Moving Average of the stock is -6.48%, while the 200-Day Moving Average is calculated to be 9.77%.
Shares Statistics:
It appears that CLBT traded 1.87M shares on average per day over the past three months and 1199360 shares per day over the past ten days. A total of 234.52M shares are outstanding, with a floating share count of 107.50M. Insiders hold about 55.11% of the company’s shares, while institutions hold 36.25% stake in the company. Shares short for CLBT as of 1741910400 were 1275179 with a Short Ratio of 0.68, compared to 1739491200 on 909744. Therefore, it implies a Short% of Shares Outstanding of 1275179 and a Short% of Float of 1.0999999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
